Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention

Table 4

Repeated laboratory data collected in the hospital.

	TMZ group (n = 200)	Control group (n = 201)	value
CK on day 2 (U/L)	838 ± 732	1046 ± 1048	0.022
CKMB on day 2 (U/L)	86 ± 71	106 ± 104	0.022
CRP on day 2 (pg/ml)	101.5 ± 193.5	121.1 ± 225.9	0.554
TNF-α on day 2 (pg/ml)	51.3 ± 83.4	51.8 ± 87.4	0.968
cTNI on day 2 (ng/ml)	14.3 ± 14.5	17.0 ± 17.9	0.092
cTNI on day 6 (ng/ml)	3.5 ± 3.5	4.7- ± 4.9	0.003
ALT on day 6 (U/L)	33.8 ± 25.0	43.6 ± 32.7	0.001
AST on day 6 (U/L)	42.1 ± 26.8	62.8 ± 54.8	<0.001
Cr on day 6 (μmo l/L)	80.7 ± 26.3	82.2 ± 28.0	0.583
Urea on day 6 (mmol/L)	6.3 ± 4.8	6.5 ± 11.6	0.843
Glucose on day 6 (mmol/L)	6.0 ± 1.7	6.4 ± 1.9	0.011

All comparisons were two-tailed, and was considered statistically significant.